Skip to content
Home/Companies/Biotech/Noema Pharma
NP

Noema Pharma

Biotech·Switzerland·Active·3yr hold

Noema Pharma is a healthcare / biotech company, headquartered in Switzerland.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Noema Pharma?

Noema Pharma is currently owned by Jeito Capital through Jeito I (2021 vintage), since 2023. Across its history, Noema Pharma has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Jeito Capital
Most recent investor
Jeito Capital
Jeito I · 2021 · VC
2 ownership periods · full history below

Key facts

HQSwitzerland
SectorHealthcare / Biotech

Ownership history

2 ownership periods

Active
Currently held by Jeito Capital since 2023.
Sofinnova Partners
Sofinnova PartnersExited 2022
2020 · 2022 · Sofinnova Capital IX · 2018 · Life Sciences VC
to
MOIC
–
Jeito Capital
Jeito CapitalActive
2023 · present · Jeito I · 2021 · VC
MOIC
–

More from Jeito I

Other portfolio companies in the same fund.

Corteria Pharmaceuticals
Active
BiotechFrance· 2023
Advesya
Active
BiotechSpain· 2022
CatalYm
Active
BiotechGermany· 2022
CDR-Life
Active
BiotechSwitzerland· 2022
EyeBio
Exited 2024
BiotechUS· 2022
to
NMD Pharma
Active
BiotechDenmark· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings